Physician profile
Carol A White
NPI 1417028887
$2,061.50
in general payments reported to CMS, 2019-2025
16 companies · $40.57 in 2025
The $40.57 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $201 · 2021: $343 · 2022: $173 · 2023: $560 · 2024: $459 · 2025: $40.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,059.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $625.61 | 2021-2023 | Venaseal, Closurefast |
| Tactile Systems Technology INC | $427.71 | 2023-2024 | Flexitouch Plus, Entre Plus |
| Medtronic Vascular, INC. | $308.36 | 2019-2020 | |
| Janssen Biotech, INC. | $265.64 | 2022-2025 | Tremfya, Simponi, Stelara |
| Bard Peripheral Vascular, INC. | $139.16 | 2020 | |
| Ucb, INC. | $58.34 | 2024 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $46.31 | 2024 | Dupixent |
| Lilly USA, LLC | $35.25 | 2021 | |
| Vyne Pharmaceuticals INC. | $26.59 | 2021 | |
| Sun Pharmaceutical Industries INC. | $25.95 | 2020 | |
| Amgen INC. | $23.02 | 2022 | |
| Incyte Corporation | $20.81 | 2024 | Opzelura |
| Pfizer INC. | $18.35 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.38 | 2023 | Cyltezo |
| Mission Pharmacal Company | $12.70 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermira, INC. | $12.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.